Multimorbidity clusters and their association with secondary bacterial infections and disease severity among hospitalised COVID-19 patients in Victoria, Australia: Insights from population-wide linked data
Journal of Multimorbidity and Comorbidity · 2026-07 · 16
DOI: 10.1177/26335565261474085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Multimorbidity and Comorbidity, online erschienen am 04.08.2026. Verfasst von Michael Muleme und 5 weiteren Autor:innen. Beteiligte Einrichtung: Barwon South West Public Health Unit, Barwon Health, Geelong, Victoria, Australia. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Victorian Post-Acute COVID-19 sequelae group.
Abstract (Originalsprache)
Background
Limited evidence exists on how multimorbidity combinations influence the risk of secondary bacterial infections. This study identified multimorbidity clusters among hospitalised COVID-19 patients in Victoria (2020–2023) and examined their association with secondary bacterial infections and admission outcomes, including ICU admission, hospital and ICU length of stay, and mortality.
Methods
We used population-wide linked hospital data and applied cluster analysis to ICD-10 coded chronic conditions to identify multimorbidity clusters. Risks of secondary bacterial infection across clusters were compared to patients with one or no chronic conditions. We used multivariate logistic regression, negative binomial regression, Kaplan–Meier curves, and Cox proportional hazards models to analyse associations with secondary bacterial infection and admission outcomes.
Results
Among 179,688 COVID-19 hospital admissions, three multimorbidity clusters were identified: neuropsychiatric, cardiometabolic-multisystem, and neoplastic. Compared to no multimorbidity, each cluster was associated with significantly higher odds of secondary bacterial infection: neuropsychiatric (Odds Ratio (OR) 2.74, 95% CI 2.59–2.89), cardiometabolic-multisystem (OR 3.87, 95% CI 3.63–4.13), and neoplastic (OR 1.98, 95% CI 1.84–2.14; all p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barwon South West Public Health Unit, Barwon Health, Geelong, Victoria, Australia.
- Centre for Innovation in Infectious Disease and Immunology Research, Deakin University, Geelong, Victoria, Australia.
- Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.
- School of Medicine, Deakin University, Geelong, Victoria, Australia.
- Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, Victoria, Australia.
ORCID-Profile: Michael Muleme
Förderung
- Victorian Post-Acute COVID-19 sequelae group
Zitieren
APA
Muleme, M., Hayes, M., McNamara, B., Clarke, N., Athan, E., & Hussain, M. A. (2026). Multimorbidity clusters and their association with secondary bacterial infections and disease severity among hospitalised COVID-19 patients in Victoria, Australia: Insights from population-wide linked data. Journal of Multimorbidity and Comorbidity, 16. https://doi.org/10.1177/26335565261474085
Vancouver
Muleme M, Hayes M, McNamara B, Clarke N, Athan E, Hussain MA. Multimorbidity clusters and their association with secondary bacterial infections and disease severity among hospitalised COVID-19 patients in Victoria, Australia: Insights from population-wide linked data. Journal of Multimorbidity and Comorbidity. 2026;16. doi:10.1177/26335565261474085
BibTeX
@article{Muleme2026,
author = {Muleme, Michael and Hayes, Mark and McNamara, Bridgette and Clarke, Naomi and Athan, Eugene and Hussain, Mohammad Akhtar},
title = {Multimorbidity clusters and their association with secondary bacterial infections and disease severity among hospitalised COVID-19 patients in Victoria, Australia: Insights from population-wide linked data},
journal = {Journal of Multimorbidity and Comorbidity},
year = {2026},
volume = {16},
doi = {10.1177/26335565261474085}
}
EUVIMED